Thursday, May 31, 2012

The report claims U.S.A. labels the other use and supervises to do one's best to medicines

The report claims U.S.A. labels the other use and supervises to do one's best to medicines
The report claims U.S.A. labels the other use and supervises to do one's best to medicines
Washington, July 27 (Xinhuanet) the government under the US Congress asks the responsibility office and releases saying a few days ago, because relevant regulations store in in the contradictory place, in addition, lack the special supervisor, American Food and Drug Administration labels the other use to supervise to do one's best in medicines. What is called medicines label the other use, mean some of medicines treat the function and has not got approval and approval about organization's clinical trial, but is used in doctor,etc. the clinical treatment. Government ask responsibility office to investigate U.S.A. further recently medical medicines of field label the other use, and the relevant supervision situation of Food and Drug Administration. Invoke the government to ask the reporting to the report of the responsibility office on the 27th according to the American media, in U.S.A.'s medical field, medicines label the other use and is accepted extensively, it is supervised but scarce. Medicines may benefit some patients while labelling the other use, but the others are pure wasting the money, what the intersection of health and benefit does it will receive, have some health of people might even be damaged because of medicines side effect. Say U.S.A. label other the intersection of use and regulation of, have contradictory in medicines. For example, according to the stipulations of medicines marketing of Food and Drug Administration, medical enterprises can't recommend the medicine function not approving of this office clinical trial to medical organization. But according to the instruction that government organ put out this year, medical enterprise can provide the intersection of explanation and new medical article of use that medicines do not sanction for doctor. The doctor judges that prescribes according to individual. Say, there is no special messenger to take charge of supervising medical enterprises being in accordance with the relevant regulation of marketing of medicines in Food and Drug Administration, lack the effective following supervisory system. Because of these, in U.S.A. from find medical enterprise recommend medicines label other use, need 7 months sending the warning out on average to the administrative department illegally, and it usually also takes 4 months to let medical enterprises carry on relevantly and rectify and improve. It was implemented in conformity with the request of federal senator Charles and Grassley of Iowa state of U.S.A. that relevant medicines labelled the investigation of the other use. Grassley says in a statement, American Food and Drug Administration has not followed the situation about recommending medicines to label the other use illegally, so the medical enterprises that have have not born corresponding responsibility, " the patient's security has been ignored " .


|

No comments:

Post a Comment